GenAI literacy is not about turning everyone into a technologist. It is about teaching people how to sense-check outputs, recognise bias and know when human judgement must take precedence. In ...

The study finds that healthcare settings are a leading source of stigma for people living with rare conditions ...

Many of the people most engaged with our poster were already advocates, which may explain why the focus shifted quickly to ...

Identifying the right specialists with precision data In rare disease, access to treatment starts long before launch. Patient populations are small and dispersed, and the physicians who treat them ...

Stop pushing content at a burnt-out audience and start creating "Digital Magnetism." Join Impetus Digital to unlock the 2026 ...

Precision intelligence offers a path forward – pharma-specific, human-led and already in use by teams managing complex, ...

Under the agreement, Vivtex will license select oral drug-delivery technologies to Novo Nordisk, while Vivtex is eligible to receive upfront consideration, research funding and milestone payments ...

These rules apply to pharma. For distribution, medicine approvals and access are essential. For mental availability, brands ...

Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when ...

Ethan Mollick’s idea of the ‘jagged frontier’ of AI 1 is one of the most useful ways of describing the problem with the ...

The race to harness and exploit generative AI (GenAI) in healthcare is at a feverish state, with agencies and pharmaceutical companies building platforms and creative departments plundering ...